Dollar headwinds and diabetes setback to weigh on AstraZeneca

The British-Swedish pharma giant is expected to see revenue fall by 1.5pc in the third-quarter due to foreign exchange pressures











taken from here http://telegraph.feedsportal.com/c/32726/f/568300/s/4b21d29e/sc/21/l/0L0Stelegraph0O0Cfinance0Cnewsbysector0Cpharmaceuticalsandchemicals0C119633890CDollar0Eheadwinds0Eand0Ediabetes0Esetback0Eto0Eweigh0Eon0EAstraZeneca0Bhtml/story01.htm